Artefacts in the thin-layer chromatographic analysis of 99tcm-tetrofosmin injections

Nuclear Medicine Communications

Volumn 20, Issue 5, 1999, Pages 439-444

  Graham, D ^a   Millar, A M ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TETROFOSMIN TC 99M;

ANALYTIC METHOD; ARTICLE; ARTIFACT; ARTIFACT REDUCTION; CONCENTRATION RESPONSE; DRUG DETERMINATION; DRUG PURITY; THIN LAYER CHROMATOGRAPHY;

EID: 0032987776     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199905000-00007     Document Type: Article

References (7)

1. Higley B, Smith FW, Smith T et al. 99Tcm-l,2-bis[bis(2-ethoxyethyl) phosphino]ethane: Human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993; 34: 30-36.
2. Ishibashi M, Nishida H, Kumabe T et al. Tc-99m tetro-fosmin, a new diagnostic tracer for parathyroid imaging. Clin Nucl Med 1995; 20: 902-905.
3. Giordano A, Meduri G, Marozzi P. Parathyroid imaging with 99Tcm-tetrofosmin. Nucl Med Commun 1996; 17: 706-710.
4. Rambaldi PF, Mansi L, Proccacini E et al. Breast cancer detection with 99m-Tc-tetrofosmin. Clin Nucl Med 1995; 20: 703-705.
5. Graham D. Factors affecting the quality of 99Tcm-tetro-fosmin. MSc Thesis, University of London, 1996.
6. Graham D, Millar A. Factors affecting the sorption of 99Tcm-tetrofosmin onto glass vials. Nucl Med Commun 1997; 18: 336.
7. Robbins PJ. Chromatography of technetium-99m radiopharmaceuticals-a practical guide. New York: The Society of Nuclear Medicine, 1984.